Home
Conditions
Myelodysplastic-Myeloproliferative Diseases

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

155 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

NCT00003961

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

NCT00098683

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +7 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach, California, United States

Children's Hospital Central California Madera, California, United States

View all 85 locations

View Trial Details

Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions: Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations: CCOP - Bay Area Tumor Institute Oakland, California, United States

Children's Hospital & Research Center Oakland Oakland, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Florida Shands Cancer Center Gainesville, Florida, United States

View all 43 locations

View Trial Details

Completed

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

NCT00005863

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Birmingham Heartlands Hospital Birmingham, England, United Kingdom

View Trial Details

Completed

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT00005823

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
Locations: Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom

University College Hospital London, England, United Kingdom

University Hospital of Wales Cardiff, Wales, United Kingdom

View Trial Details

Completed

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

NCT00301938

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +56 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Progression of Hematopoietic Diseases in Shanghai, China

NCT00365014

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +11 more
Locations: Joint Sino-US Clinical and Molecular Laboratory (JCML) Shanghai, China

View Trial Details

Myelodysplastic-Myeloproliferative Diseases

Myelodysplastic-Myeloproliferative Diseases trial results

Related conditions